▼ SELL
10b5-1 Plan
$ Value
$84K
Shares
10,079
Price
$8
Filed
Mar 3
Insider
Name
Raykov Rosty
Title
—
CIK
0001468316
Roles
Director
Transaction Details
Transaction Date
2026-03-02
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
103,996
Footnotes
Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025. | Shares sold to satisfy tax obligation on option exercise. | Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024. | Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.
Filing Info
Raykov Rosty's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | FENC | M | $38K |
| 2026-04-01 | FENC | ▼ | $69K |
| 2026-04-01 | FENC | M | $38K |
| 2026-03-31 | FENC | A | $0 |
| 2026-03-02 | FENC | M | $38K |
| 2026-03-02 | FENC | ▼ | $84K |
| 2026-03-02 | FENC | M | $38K |
| 2026-02-28 | FENC | A | $0 |
| 2026-02-02 | FENC | M | $38K |
| 2026-02-02 | FENC | ▼ | $80K |
Other Insiders at FENC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Andrade Robert
CHIEF FINANCIAL OFFICER
|
— | — | 2026-03-31 |
| Raykov Rosty | — | $149K | 2026-04-01 |
|
Hackman Jeffrey S.
Chief Executive Officer
|
— | — | 2026-03-31 |
|
Evans Terry L
Chief Commercial Officer
|
— | — | 2026-03-31 |
|
Sayad Pierre Sargis
Chief Medical Officer
|
— | — | 2026-03-31 |
|
Cioffi Christiana Marie
Chief Strategy Officer
|
— | — | 2026-03-31 |